Status:
COMPLETED
To Establish a Reproducible Organoid Culture Model With Human Kidney Cancer
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Kidney Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Kidney cancer is one of the ten most common malignancies, and the incidence is increasing in recent year. From Hong Kong Cancer Registry, there was about 670 new cases diagnosed in 2016, and had been ...
Detailed Description
Kidney cancer is one of the ten most common malignancies, and the incidence is increasing in recent year. From Hong Kong Cancer Registry, there was about 670 new cases diagnosed in 2016, and had been ...
Eligibility Criteria
Inclusion
- Male patients \> 18 years old
- Patients suffered from renal cell carcinoma require surgical removal of kidney
Exclusion
- Patients fail to provide informed consent
- The collection of tissue will affect the pathological interpretation of the specimen
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 22 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04342286
Start Date
May 1 2020
End Date
February 22 2021
Last Update
December 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Shatin, Hong Kong